Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices

Authors:
  • PCPaul Calès
    Paul Calès
  • LPLinda Pasta
    Linda Pasta
  • GIGaetano Ideo
    Gaetano Ideo
  • JPJean-Pierre Pascal
    Jean-Pierre Pascal
  • LPLuigi Pagliaro
    Luigi Pagliaro
  • DLDidier Lebrec
    Didier Lebrec
  • TGthe Franco–Italian Multicenter Study Group*
    the Franco–Italian Multicenter Study Group*

Abstract
The value of beta-adrenergic—antagonist drug therapy for the prevention of initial episodes of gastrointestinal bleeding in patients with cirrhosis and esophageal varices is uncertain, both positive and negative study results having been reported.

This publication has 11 references indexed in Scilit: